Philipp Mahlknecht

Innsbruck Medical University — Austria

Medicine · Health Sciences

41h-index6.1kcitations149works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(89), Neurological disorders and treatments(78), Botulinum Toxin and Related Neurological Disorders(23), Genetic Neurodegenerative Diseases(21), Olfactory and Sensory Function Studies(16)

Publications147 total

The Utility of Olfactory Testing to Discriminate Parkinson's Disease From Diagnostic Mimics: A Systematic Review and Meta‐Analysis
European Journal of Neurology·2025Open Access
Simple diameters, accurate stages:a practical approach to HD-ISS staging
Journal of Neurology·2025Open Access
Bradykinesia induced by pallidal neurostimulation in dystonia: clinical risk factors and anatomical mapping
npj Parkinson s Disease·2025Open Access
Cognitive changes preceding Parkinson's disease: a systematic review and meta-analysis of prospective population-based studies
Frontiers in Aging Neuroscience·2025Open Access
Temporal Muscle Thickness Correlates with Functional Decline in Huntington's Disease
Movement Disorders·2025Open Access
Impact assessment of dissemination techniques on data collection in a large multicenter Healthy Brain Ageing (HeBA) survey (Preprint)
2025Open Access
Identifying individuals at-risk of developing Parkinson’s disease using a population-based recruitment strategy: The Healthy Brain Ageing Kassel Study
npj Parkinson s Disease·2025· 2 citedOpen Access
Neck and mind: exploring emotion processing in cervical dystonia
Frontiers in Neuroscience·2025Open Access
The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson’s disease
Nature Biotechnology·2025· 9 citedOpen Access
Long‐Term Outcomes on Pallidal Neurostimulation for Dystonia: A Controlled, Prospective 10‐Year Follow‐Up
Movement Disorders·2025· 5 citedOpen Access
Optical Coherence Tomography in Huntington's Disease—A Potential Future Biomarker for Neurodegeneration?
Neurology International·2025Open Access
Mapping the distribution of neurotransmitters to resting-state functional connectivity in Parkinson’s disease
Brain Communications·2025Open Access
Preferences regarding Disclosure of Risk for Parkinson's Disease in a Population‐based Study
Movement Disorders Clinical Practice·2024· 5 citedOpen Access
Objective and subjective cognitive outcomes one year after COVID‐19
Annals of Clinical and Translational Neurology·2024· 1 citedOpen Access
Mapping the distribution of neurotransmitters to resting-state functional connectivity in patients with Parkinson’s disease
2024Open Access
Long‐Term Medication Profiles in Parkinson's Disease under Subthalamic Deep Brain Stimulation: A Controlled Study
Movement Disorders Clinical Practice·2024· 2 citedOpen Access
Sex-related differences in the clinical presentation of multiple system atrophy
Clinical Autonomic Research·2024· 5 citedOpen Access
Serum Neurofilament Light and Clinical Biomarkers for Disease Staging in Huntington's Disease
Movement Disorders Clinical Practice·2024· 1 citedOpen Access
Pharmacotherapy for Disease Modification in Early Parkinson’s Disease: How Early Should We Be?
Journal of Parkinson s Disease·2024· 9 citedOpen Access
Emotion Recognition in Multiple System Atrophy: An Exploratory Eye-Tracking Study
Journal of Movement Disorders·2023Open Access
page 1 of 8Next →

Frequent Co-authors

Werner Poewe(35), Klaus Seppi(33), Stefan Kiechl(17), Heike Stockner(15), Johann Willeit(14), Christoph Scherfler(12), Arno Gasperi(11), Atbin Djamshidian(10), Michael Nocker(9), Birgit Högl(8), Thomas Foltynie(7), Patricia Limousin(7), Gregor K. Wenning(7), Gregorio Rungger(6), Florian Krismer(6), Dejan Georgiev(5), Marwan Hariz(5), Ludvic Zrinzo(5), Beatrice Heim(5), Anna Hussl(5)